Disclosures for "Comparing First-line Natalizumab and Ocrelizumab Use for the Treatment of Multiple Sclerosis: A Komodo Health Claims Database Study"
-
Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohaven. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Viela. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck.
-
Mrs. Beenstock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Mrs. Beenstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Meyer Squibb. Mrs. Beenstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
-
Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Belkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Belkin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD serono. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Belkin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Belkin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Belkin has received stock or an ownership interest from Biogen.
-
The institution of Dr. Crayton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Crayton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Crayton has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Crayton has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Crayton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Crayton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sandoz. The institution of Dr. Crayton has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Crayton has received research support from EMD Serono. The institution of Dr. Crayton has received research support from Sanofi. The institution of Dr. Crayton has received research support from Atara.
-
The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme.
-
Dr. Fredericks has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fredericks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion.
-
Boyang Bian has received personal compensation for serving as an employee of Biogen. Boyang Bian has stock in Biogen.
-
Dr. Belviso has received personal compensation for serving as an employee of Biogen.
-
Dr. Ni has received personal compensation for serving as an employee of Biogen. Dr. Ni has stock in Biogen.
-
Ms. Rutledge has received personal compensation for serving as an employee of Biogen. Ms. Rutledge has stock in Biogen.